- Home
- BODI vs FGEN Comparison
BODI vs FGEN Comparison
Compare BODI & FGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BODI
- FGEN
- Stock Information
- Founded
- BODI 1998
- FGEN 1993
- Country
- BODI United States
- FGEN United States
- Employees
- BODI N/A
- FGEN N/A
- Industry
- BODI Industrial Machinery/Components
- FGEN Biotechnology: Pharmaceutical Preparations
- Sector
- BODI Industrials
- FGEN Health Care
- Exchange
- BODI Nasdaq
- FGEN Nasdaq
- Market Cap
- BODI 25.4M
- FGEN 33.5M
- IPO Year
- BODI N/A
- FGEN 2014
- Fundamental
- Price
- BODI $3.97
- FGEN $7.44
- Analyst Decision
- BODI Strong Buy
- FGEN Strong Buy
- Analyst Count
- BODI 3
- FGEN 1
- Target Price
- BODI $10.67
- FGEN $250.00
- AVG Volume (30 Days)
- BODI 20.0K
- FGEN 66.4K
- Earning Date
- BODI 08-05-2025
- FGEN 08-05-2025
- Dividend Yield
- BODI N/A
- FGEN N/A
- EPS Growth
- BODI N/A
- FGEN N/A
- EPS
- BODI N/A
- FGEN N/A
- Revenue
- BODI $371,113,000.00
- FGEN $6,996,000.00
- Revenue This Year
- BODI N/A
- FGEN N/A
- Revenue Next Year
- BODI N/A
- FGEN N/A
- P/E Ratio
- BODI N/A
- FGEN N/A
- Revenue Growth
- BODI N/A
- FGEN N/A
- 52 Week Low
- BODI $3.38
- FGEN $4.50
- 52 Week High
- BODI $8.71
- FGEN $38.25
- Technical
- Relative Strength Index (RSI)
- BODI 49.25
- FGEN 64.36
- Support Level
- BODI $3.81
- FGEN $7.03
- Resistance Level
- BODI $4.43
- FGEN $5.73
- Average True Range (ATR)
- BODI 0.27
- FGEN 0.50
- MACD
- BODI 0.02
- FGEN 0.35
- Stochastic Oscillator
- BODI 44.58
- FGEN 100.00
About BODI The Beachbody Company Inc. Class A Common Stock
The Beachbody Co Inc is a health and wellness platform providing fitness, nutrition and stress-reducing programs to its customers. The product offerings of the company include Digital Subscriptions, Nutritional Products, and Connected Fitness Products. It earns the majority of its revenue from the United States. The company operates and manages its business in one operating segment. Majority of revenue is through Digital.
About FGEN FibroGen Inc
FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates. Geographically, it operates in United States, Japan, Europe and Others.